[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pelvic-pain-associated-with-endometriosis-or-adenomyosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pelvic-pain-associated-with-endometriosis-or-adenomyosis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100647846","pelvic-floor-muscle-function-and-endometriosis-related-pelvic-pain-100647846",false,"NCT07713108","Pelvic Floor Muscle Function and Endometriosis-Related Pelvic Pain","Pelvic Pain and Pelvic Floor Muscle Function in Women With Endometriosis: Preliminary Findings From a Pilot Feasibility Case-Control Study","Inclusion Criteria:\n\n* Women aged 18-50 years of reproductive age with self-reported endometriosis will be included in the study group, while women aged 18-50 years of reproductive age who are gynecologically healthy and report no history of endometriosis will be included in the control group. Additional inclusion criteria include adequate proficiency in the Hungarian language, access to the internet, and provision of informed consent.\n\nExclusion Criteria:\n\n* Exclusion criteria include lack of capacity to provide informed consent, severe physical or cognitive impairment, pregnancy, postpartum period, diagnosed malignant disease, or the presence of vaginal infection or inflammation.",true,"FEMALE","18 Years","48 Years",{"count":21,"type":22},100,"ESTIMATED","OBSERVATIONAL","Our study aims to investigate the associations between endometriosis-related pelvic pain and pelvic floor muscle strength, endurance, and relaxation ability, as well as quality of life, physical activity, and the presence of pelvic floor symptoms. Furthermore, it aims to assess the function of muscles synergistic with the pelvic floor in comparison with healthy controls.",[26,27,28],"Endometriosis","Chronic Pelvic Pain","Pelvic Pain Associated With Endometriosis or Adenomyosis",[26,30,31,32],"pelvic pain","pelvic floor muscle","manometry","RECRUITING","2026-07-14",{"date":36,"type":37},"2026-07-20","ACTUAL",{"date":39,"type":37},"2026-04-01",{"date":41,"type":22},"2028-09-01",{"name":43,"class":44},"University of Pecs","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":45},"100623181","efficacy-and-tolerability-of-tens-in-endometriosis-related-pain-100623181","NCT07393295","Efficacy and Tolerability of TENS in Endometriosis-related Pain","Evaluation of the Efficacy and Tolerability of a Transcutaneous Electrical Nerve Stimulation (TENS) Device for the Management of Endometriosis-associated Pain","ELECTRE","Inclusion Criteria:\n\n1. Women aged ≥ 18 years\n2. Endometriosis and\u002For adenomyosis diagnosed by imaging and\u002For histology\n3. Undergoing continuous, stable, and functional hormone treatment (with no menstruation) for at least 2 months\n4. No change in hormone treatment planned for the duration of the study\n5. Chronic pelvic pain for more than 6 months\n6. Pelvic pain at least equal to 2 out of 3 (on the intensity scale: \"0 - None,\" \"1 - Mild,\" \"2 - Moderate,\" \"3 - Severe\")\n7. Agreeing to participate in the study\n8. Agrees to limit pain relief treatment during the study to level I painkillers paracetamol and Acupan® (nefopam), and the NSAID Antadys® (flurbiprofen)\n9. Has a computer, tablet, or cell phone with an internet connection\n10. Is affiliated with a social security system or is a beneficiary of such a system\n\nExclusion Criteria:\n\n1. Pregnant or breastfeeding women\n2. Menopausal women\n3. Patients who, in the investigator's opinion, have experienced an acute worsening of endometriosis symptoms in the last 28 days\n4. Patients with altered sensitivity in the area where the device is applied (hypoesthesia)\n5. Skin allergy to the gel or electrodes\n6. Dermatological problem in the stimulation area\n7. Patients with an implanted pacemaker or active implanted medical device.\n8. Epilepsy\n9. Current thrombophlebitis or arterial thrombosis\n10. Cancer or malignant disease with an expected survival of \\\u003C 12 months\n11. Alcoholism or drug addiction\n12. Fibromyalgia\n13. Women who have already tried TENS\n14. Patients unable to understand and use the English language to communicate fluently\n15. Patients with cognitive impairments\n16. Untreated severe psychiatric illness and\u002For psychological condition that is the primary determinant of the patient's condition\n17. Participation in another intervention study that may impact the results of the current study\n18. Patient using \\> 90 morphine equivalents\u002Fday (at least once in the last 28 days)\n19. Gynecological and\u002For endometriosis surgery planned within the next 3 months\n20. History of endometriosis surgery within the last 6 months\n21. Patient who has undergone a hysterectomy or bilateral oophorectomy\n22. Patient under legal protection (guardianship or conservatorship) or patient deprived of liberty",{"count":55,"type":22},92,"INTERVENTIONAL",[58],"NA","ELECTRE is a single-center, randomized, prospective, longitudinal, controlled, two-arm, single-blind study lasting 4 weeks (P1 investigation phase) after a 4-week run-in period.\n\nThe study is followed by a 4-week extension phase (P2) in which all participants will be treated with active TENS.\n\nRandomization will be balanced according to a 1:1 ratio.",[28,61,26],"Pelvic Pain Associated With Refractory Endometriosis","2026-03-30",{"date":64,"type":37},"2026-03-31",{"date":66,"type":37},"2026-03-15",{"date":68,"type":22},"2027-12-31",{"name":70,"class":71},"Monath Electronic","INDUSTRY"]